Position:Vice Chair of Hematology
Department:Hematology
Medical School:Zhejiang University School of Medicine, China
Academic Rank:Chief Physician
Diagnosis and treatment of hematopoietic tumor including multiple myeloma, lymphoma and leukemia
Clinical Teaching Award, Zhejiang University
Member, Hematology Committee, Zhejiang Anti-Cancer Association, 2018-present
Committee Member, Zhejiang Society of Hematology, 2019-present
The etiology study of lymphoma and myeloma, diagnosis, molecular and genomic advance in the hematology field.
Yun Liang, Luyin Ding, Xian Li, Weiqin Wang, Xiaohong Zhang.Oculomotor nerve palsy as a preceding symptom of adult sporadic Burkitt lymphoma: A case report and review of the literature.Oncol Lett. 2017;13(3): 1315–1318.
Liang Y, Gao J, Wu D, Li S, Chen H, Ding L, Tong J, Xu Y.Long-Term Remission following Autologous Hematopoietic Cell Transplantation in a Patient with Multiple Nonleukemic Myeloid Sarcoma and a Review of the Literature.Acta Haematol. 2017;137(3):117-122.
Liang Y, He X, Li X, Zhang X, Zhang X, Zhang L, Qiu X, Zhao X, Xu R. 4-Chlorbenzoyl Berbamine, a Novel Derivative of the Natural Product Berbamine, Potently Inhibits the Growth of Human Myeloma Cells by Modulating the NF-κB and JNK Signalling Pathways. Cancer Invest. 2016;34(10):496-505.
Liang Y, Li X, He X, Qiu X, Jin XL, Zhao XY, Xu RZ. Polyphyllin I induces cell cycle arrest and apoptosis in human myeloma cells via modulating β-catenin signaling pathway. Eur J Haematol. 2016;97(4):371-378.
Liang Y, Ding L, Li X, Wang W, Zhang X. Transient pancytopenia preceding adult acute lymphoblastic leukemia with chromosomal abnormalities including the Philadelphia chromosome: A case report and review of the literature. Oncol Lett. 2015;10(6):3789-3792.
Molecular mechanisms of berbamine derivatives inhibit proliferation and eliminate cancer stem cells in myeloma via CaMKIIγ kinase. Funding Source: Natural Science Foundation of Zhejiang.
The correlation between APOBEC3B functional complex and TP53 gene mutation in Diffuse large B-cell lymphoma. Funding Source: Natural Science Foundation of Zhejiang.
4-chlorobenzoyl berbamine, a novel nuclear factor κB inhibitor, inhibits growth and induces apoptosis in myeloma cells. Funding Source: National Natural Science Foundation of China.
The molecular mechanisms of 4-chlorobenzoyl berbamine targets anti-myeloma through Wnt/β-catenin pathway. Funding Source: Natural Science Foundation of Zhejiang.
The new p53 target genes TMEM endoplasmic reticulum in the cell protective effect of emergency. Funding Resource: National Natural Science Foundation of China.
Identify of APOBEC3B functional complex in hepatocarcinogenesis. Funding Source: National Natural Science Foundation of China.
Effects of calmodulin antagonist berbamine on TGF-β/Smad signaling in human leukemia cells. Funding Source: Natural Science Foundation of Zhejiang.